US BROKER MOVES: AA upgraded at UBS; INSP downgraded at BofA
SourceNewsquawk
SectionUS Equities
UPGRADES
- Alcoa (AA) upgraded to Buy at UBS; PT USD 80 (prev. USD 75)
- Bloom Energy (BE) upgraded to Outperform at Daiwa Securities; PT USD 324
- CAVA Group (CAVA) upgraded to Buy at Argus; PT USD 92
- Generac (GNRC) upgraded to Buy at Jefferies; PT USD 302 (prev. USD 239)
- Haemonetics (HAE) upgraded to Buy at BofA Securities; PT USD 80 (prev. USD 72)
- NIO (NIO) upgraded to Buy at CMB International Securities; PT USD 7
- NetEase (NTES) upgraded to Buy at 86Research
- Texas Instruments (TXN) upgraded to Buy at Seaport Global Securities; PT USD 400
- Viking Holdings (VIK) upgraded to Buy at Truist Securities; PT USD 102 (prev. USD 75)
- Zoom Communications (ZM) upgraded to Sector Weight at KeyBanc
DOWNGRADES
- BHP Group (BHP) downgraded to Neutral at BofA Securities
- Endava (DAVA) downgraded to Underweight at JPMorgan; PT USD 5 (prev. USD 9)
- Deckers Outdoor (DECK) downgraded to Neutral at KGI Securities; PT USD 117
- Dollar General (DG) downgraded to Hold at Gordon Haskett; PT USD 140 (prev. USD 110)
- Inspire Medical Systems (INSP) downgraded to Neutral at BofA Securities; PT USD 39
- Rio Tinto (RIO) downgraded to Neutral at BofA Securities
- Summit Therapeutics (SMMT) downgraded to Neutral at H.C. Wainwright
INITIATIONS
- Ameresco (AMRC) initiated at New Neutral at Guggenheim
- Alto Neuroscience (ANRO) initiated at New Outperform at Wolfe Research; PT USD 35
- Commercial Metals (CMC) initiated at New Equalweight at Barclays; PT USD 75
- Compass Pathways (CMPS) initiated at New Outperform at Wolfe Research; PT USD 18
- Eos Energy Enterprises (EOSE) initiated at New Buy at Needham; PT USD 11
- Essent Group (ESNT) initiated at New Sector Perform at RBC Capital; PT USD 68
- Elastic (ESTC) initiated at New Outperform at William Blair
- Immunic (IMUX) initiated at New Outperform at Wolfe Research; PT USD 25
- MGIC Investment (MTG) initiated at New Sector Perform at RBC Capital; PT USD 28
- NMI Holdings (NMIH) initiated at New Outperform at RBC Capital; PT USD 46
- Oklo (OKLO) initiated at New Buy at BofA Securities; PT USD 80
- Q32 Bio (QTTB) initiated at New Outperform at Mizuho; PT USD 14
- Radian Group (RDN) initiated at New Outperform at RBC Capital; PT USD 47
- SAB Biotherapeutics (SABS) initiated at New Buy at Citi; PT USD 11
- NuScale Power (SMR) initiated at New Neutral at BofA Securities; PT USD 12
- Sensei Biotherapeutics (SNSE) initiated at New Buy at Citi; PT USD 55